Targeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymers.

[1]  N. Volkow,et al.  Putrescine metabolism in human brain tumors , 1986, Journal of Neuro-Oncology.

[2]  Robert J. Lee,et al.  Folate Receptor-Mediated Liposomal Delivery of a Lipophilic Boron Agent to Tumor Cells in Vitro for Neutron Capture Therapy , 2002, Pharmaceutical Research.

[3]  B. Tirosh,et al.  Mucus Gel Thickness and Turnover in the Gastrointestinal Tract of the Rat: Response to Cholinergic Stimulus and Implication for Mucoadhesion , 1994, Pharmaceutical Research.

[4]  J. Jass,et al.  Correlative histochemical study providing evidence for the dual nature of human colorectal cancer mucin , 2004, The Histochemical Journal.

[5]  R. Goldberg,et al.  Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived , 2003, Expert Opinion on Investigational Drugs.

[6]  Thomas Kissel,et al.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. , 2003, Biomaterials.

[7]  E. Kreimann,et al.  Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch. , 2003, Archives of oral biology.

[8]  R. Müller,et al.  Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy. , 2003, Bioconjugate chemistry.

[9]  M. Caligiuri,et al.  Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas. , 2002, Cancer research.

[10]  M. Ciesielski,et al.  Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas. , 2002, Cancer research.

[11]  P. Hermanek,et al.  Locoregional recurrence in patients with anastomotic leakage after anterior resection for rectal carcinoma , 2001, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[12]  S. Haupt,et al.  Drug targeting by surface cationization. , 2000, Critical reviews in therapeutic drug carrier systems.

[13]  M. Hawthorne,et al.  Applications of Radiolabeled Boron Clusters to the Diagnosis and Treatment of Cancer. , 1999, Chemical reviews.

[14]  M. Wilchek,et al.  Ion exchange tumor targeting: a new approach. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  A. Varki,et al.  Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. , 1999, The American journal of pathology.

[16]  P. Sugarbaker,et al.  Successful management of microscopic residual disease in large bowel cancer , 1999, Cancer Chemotherapy and Pharmacology.

[17]  G. Houin,et al.  The improved everted gut sac: a simple method to study intestinal P-glycoprotein , 1998 .

[18]  S. Stass,et al.  In vivo gene therapy with a cationic polymer markedly enhances the antitumor activity of antiangiogenic genes. , 1998, Molecular genetics and metabolism.

[19]  R. Barth,et al.  The Chemistry of Neutron Capture Therapy. , 1998, Chemical reviews.

[20]  R. Greger,et al.  Effects of the carcinogen dimethylhydrazine (DMH) on the function of rat colonic crypts , 1996, Pflügers Archiv.

[21]  Y. Kim,et al.  Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. , 1996, Gastroenterology.

[22]  R. Reisfeld,et al.  Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors. , 1995, Journal of hematotherapy.

[23]  M. Hawthorne,et al.  Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Rubinstein,et al.  The role of cationized catalase and cationized glucose oxidase in mucosal oxidative damage induced in the rat jejunum. , 1992, The Journal of biological chemistry.

[25]  M. Hawthorne,et al.  Model studies directed toward the boron neutron-capture therapy of cancer: boron delivery to murine tumors with liposomes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Bresalier,et al.  The role of mucin in colon‐cancer metastasis , 1992, International journal of cancer.

[27]  E. Mechetner,et al.  Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy. , 1991, Analytical chemistry.

[28]  R. Dahiya,et al.  Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. , 1991, The Journal of clinical investigation.

[29]  B. Allen,et al.  Determination of boron in biological tissues by inductively coupled plasma atomic emission spectrometry. , 1987, Analytical chemistry.

[30]  V. Bond,et al.  Current status of 10B-neutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: a theoretical evaluation. , 1985, International journal of radiation oncology, biology, physics.

[31]  N. Mor,et al.  The Sabra rat: definition of a laboratory animal. , 1984, Israel journal of medical sciences.

[32]  N. Volkow,et al.  Labeled putrescine as a probe in brain tumors. , 1983, Science.

[33]  P. Altevogt,et al.  Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation , 1983, The Journal of experimental medicine.

[34]  C. Lloyd.  SIALIC ACID AND THE SOCIAL BEEIAVIOUR OF CELLS , 1975, Biological reviews of the Cambridge Philosophical Society.

[35]  M. Abercrombie,et al.  The surface properties of cancer cells: a review. , 1962, Cancer research.